We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$28.5B
AUM Growth
-$1.64B
Cap. Flow
-$541M
Cap. Flow %
-1.9%
Top 10 Hldgs %
23.41%
Holding
1,182
New
104
Increased
354
Reduced
497
Closed
123

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$94.3M
2
MSFT icon
Microsoft
MSFT
+$65.5M
3
LLY icon
Eli Lilly
LLY
+$58.4M
4
NVDA icon
NVIDIA
NVDA
+$58M
5
ABBV icon
AbbVie
ABBV
+$43.8M

Top Sells

Rank Stock Value
1
SLAB icon
Silicon Laboratories
SLAB
+$84.9M
2
ATVI
Activision Blizzard
ATVI
+$78.4M
3
BAC icon
Bank of America
BAC
+$64.2M
4
MA icon
Mastercard
MA
+$60.4M
5
MMM icon
3M
MMM
+$55.1M

Sector Composition

Rank Sector Weight
1 Technology 33.32%
2 Healthcare 19.18%
3 Consumer Discretionary 12.28%
4 Financials 8.16%
5 Industrials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACGL icon
226
Arch Capital
ACGL
$36.5B
$26M 0.09%
325,872
-123,114
-27% -$9.58M
GEN icon
227
Gen Digital
GEN
$16.5B
$25.8M 0.09%
1,461,867
-264,727
-15% -$5.17M
O icon
228
Realty Income
O
$61.1B
$25.3M 0.09%
505,972
-2,762
-0.5% -$159K
AMP icon
229
Ameriprise Financial
AMP
$47.8B
$25.2M 0.09%
76,328
+45,613
+149% +$15.6M
COLD icon
230
Americold
COLD
$4.21B
$25M 0.09%
821,125
-158,496
-16% -$5.13M
CHD icon
231
Church & Dwight Co
CHD
$23.7B
$24.9M 0.09%
271,873
+25,288
+10% +$2.42M
BNY
232
Bank of New York Mellon
BNY
$103B
$24.7M 0.09%
578,029
+428,603
+287% +$19.1M
ATVI
233
DELISTED
Activision Blizzard
ATVI
$24.6M 0.09%
262,703
-859,679
-77% -$78.4M
HCA icon
234
HCA Healthcare
HCA
$90.6B
$24.4M 0.09%
99,123
-12,623
-11% -$3.45M
CI icon
235
Cigna
CI
$78.4B
$24.1M 0.08%
84,252
-2,902
-3% -$828K
AEM icon
236
Agnico Eagle Mines
AEM
$72.2B
$24M 0.08%
529,011
-194,197
-27% -$9.52M
AMBA icon
237
Ambarella
AMBA
$3.04B
$23.9M 0.08%
451,140
-87,934
-16% -$6.17M
IBM icon
238
IBM
IBM
$213B
$23.5M 0.08%
167,682
+5,766
+4% +$820K
CALX icon
239
Calix
CALX
$2.24B
$23.5M 0.08%
512,140
+22,290
+5% +$1.01M
TD icon
240
Toronto Dominion Bank
TD
$193B
$23.4M 0.08%
388,581
-939
-0.2% -$58.5K
CXM icon
241
Sprinklr
CXM
$1.51B
$23.4M 0.08%
1,687,970
+447,064
+36% +$6.4M
STT icon
242
State Street
STT
$48.4B
$23.3M 0.08%
348,095
-5,351
-2% -$377K
DOC icon
243
Healthpeak Properties
DOC
$15.5B
$23M 0.08%
1,255,224
+65,579
+6% +$1.35M
DAVA icon
244
Endava
DAVA
$165M
$22.9M 0.08%
400,033
+2,749
+0.7% +$143K
UDR icon
245
UDR
UDR
$12.9B
$22.7M 0.08%
635,274
-28,753
-4% -$1.15M
DIS icon
246
Walt Disney
DIS
$171B
$22.6M 0.08%
279,231
-46,861
-14% -$4M
ARE icon
247
Alexandria Real Estate Equities
ARE
$9.37B
$22.5M 0.08%
225,241
+37,430
+20% +$4.35M
SYK icon
248
Stryker
SYK
$135B
$22.4M 0.08%
82,135
-6,722
-8% -$1.93M
KR icon
249
Kroger
KR
$36.7B
$22.3M 0.08%
497,641
-265,181
-35% -$12.5M
CSX icon
250
CSX Corp
CSX
$94B
$22.3M 0.08%
723,922
-98,123
-12% -$3.11M

Similar funds

Axa's Q3 2023 Portfolio in Review

As of Q3 2023, Axa held 1,182 positions worth $28.5B, down 5.5% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Axa's Q3 2023 filing shows 104 new, 354 increased, 497 reduced and 123 closed positions. Its largest new stake was Invesco: 1,126,202 shares worth $16.4M. The largest sale was Silicon Laboratories, an estimated $84.9M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q3 2023 buy was Invesco: 1,126,202 shares worth $16.4M.
  • Axa added most to Applied Materials in Q3 2023, an estimated $94.3M increase.
  • Axa's biggest Q3 2023 reduction was Silicon Laboratories, cutting an estimated $84.9M.
  • Axa fully exited Life Storage, Inc. in Q3 2023, selling an estimated $19.3M.
  • Axa's ten largest holdings make up 23% of its $28.5B portfolio in Q3 2023.
  • Axa opened 104 new positions and closed 123 in Q3 2023.
  • Axa's portfolio value fell 5.5% quarter-over-quarter to $28.5B.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.